OFFICIAL PUBLICATION OF

pdl.com.au

by its subsidiary APPco

Substitution alert

Sheshtyn Paola 20/09/2021

New medicine added for pharmacist substitution due to serious shortages Pharmacists are now able to substitute isosorbide mononitrate 60 mg modified release tablets for isosorbide mononitrate 120 mg modified release tablets without prior approval from the prescriber under the TGA's new Serious Scarcity Substitution Instrument (SSSI), “so long as the permitted circumstances provided within the

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart

Eli Lilly clarifies Mounjaro availability

Lilly doesn't have needle production facilities. That is not their fault, you can't expect them to build a needle factory…

Tony Chiang

Funding secured for non-8CPA programs

Well done! Good to see pharmacy profession progressions

Wilson Tan

Funding secured for non-8CPA programs

Medschecks are part of the 8CPA. Have already had secured funding with indexation despite no evidence of value.

Big Pharma